General contractor Mortenson topped out the third building of Serán Bioscience’s new 100,000-square-foot commercial manufacturing campus in Bend, Oregon, according to a Jan. 8 ceremony.
The milestone marks the transition from structural construction to the interior buildout, according to the Minneapolis-based contractor. The third building, which is the centerpiece of the campus, will ultimately position the Bend area as a major hub for advanced pharmaceutical development, according to a Mortenson news release sent to Construction Dive.
Serán Bioscience, a drug development company, did not officially disclose the total value of the project. But in a 2024 news release, the firm said the build was supported by a $200 million strategic growth transaction with Bain Capital Life Sciences.
“Serán’s project reflects the level of technical complexity and quality standards we see driving growth in life sciences manufacturing today,” Pat Clemons, project executive with Mortenson, said in the release. “Our team is proud to support a facility that is purpose-built for advanced pharmaceutical production while contributing to the long-term economic strength of the Bend region.”
The campus, located near Serán’s existing 90,000-square-foot clinical development and manufacturing campus, will operate as an extension of the company’s established clinical operations. The expansion follows Serán’s move last fall to complete two new warehouse and light manufacturing buildings, totaling about 50,000 square feet, according to the release.
Once complete, these spaces will support critical materials handling, packaging, labeling and logistics functions.
“This is a significant life sciences project for Central Oregon,” Mike Clifford, vice president and general manager at Mortenson, said in the release. “By delivering flexible, science-driven facilities, we’re helping translate innovation into commercially viable therapies while contributing to the continued growth of the region’s life sciences market.”
Mortenson expects the facility to begin operations in the second quarter of 2027, according to the release.
